<DOC>
	<DOCNO>NCT02114645</DOCNO>
	<brief_summary>This prospective clinical trial evaluates effect two dose GnRH agonist administer luteal phase outcome ART cycle stimulate long GnRH agonist GnRH antagonist protocol .</brief_summary>
	<brief_title>The Effect GnRH Agonist Administered Luteal Phase ART Cycle Outcomes</brief_title>
	<detailed_description>This prospective clinical trial evaluates effect two dose GnRH agonist administer luteal phase outcome ART cycle stimulate long GnRH agonist GnRH antagonist protocol . Decision two protocol subjective depend clinical context.In addition routine luteal phase support progesterone estradiol valerate , woman receive two dose GnRH agonist fifth tenth day ET.Live birth rate primary outcome measure .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Leuprolide</mesh_term>
	<mesh_term>Triptorelin Pamoate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Deslorelin</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<criteria>Couples undergo ART gamete . Couples least one good embryo available transfer . Normoresponder Infertility etiology unexplained ovulation trigger intramuscular injection 10000 IU HCG Patients old 38 year old High poor responder patient</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Luteal phase support , GnRH agonist , ART cycle</keyword>
</DOC>